The Board of Directors of Ontex has appointed Mr. Gustavo Calvo Paz as new Chief Executive Officer, with effect from November 14, 2022, succeeding Ms. Esther Berrozpe.
“I feel honored and energized to contribute to the acceleration of Ontex’s strategy. Together with the leadership team and all of our talented employees, we will build the next phase of the transformation, focusing on strengthening and growing our partner brands & healthcare in Europe and North America and continue our exploration of strategic alternatives for our branded business,” Paz stated, after his appointment.
Calvo Paz has a deep understanding of the industry and has vast category knowledge and international experience in operations and strategy within the sector. Born in Argentina and leading operations across Latin America, North America and Europe throughout his career, Mr. Calvo Paz has extensive prior leadership experience, including as an executive member of Kimberly-Clark’s Global Leadership Team.
Since 2018, he has been advising investors and boards of publicly listed companies, including Ontex, when he joined the Board of Directors in May 2021. With this appointment, Mr. Calvo Paz will resign from the Ontex Board of Directors.
“We are committed to the strategy we presented at the end of last year. As Ontex is entering the next phase of its transformation, the Board of Directors believes that Mr. Calvo Paz is the right person to accelerate the execution of our strategy. The Board and I look forward to work with Gustavo and the management team towards building the New Ontex,” declared Hans Van Bylen, Chairman of the Board.
In addition to welcoming the new CEO, the Board of Directors also thanked Esther Berrozpe for her strong contribution to Ontex as the company’s leader. During her tenure, the company revised its strategy, advanced in the reformulation of the portfolio and managed an inflationary environment.